[Asia Economy Reporter Myunghwan Lee] SD Biosensor, a company specializing in in vitro diagnostics, announced on the 20th that its consolidated sales for last year amounted to KRW 2.93 trillion, a 0.1 ...

SUWON, South Korea--(BUSINESS WIRE)--SD Biosensor, Inc., a global in-vitro diagnostics company, is voluntarily recalling its STANDARD Q COVID-19 Ag Home Test in the United States, due to confirmed ...

The number of new COVID-19 cases is breaking records day after day. To respond to the spread of the Omicron variant, the government has shifted the COVID-19 diagnostic testing system to focus on ...

SD Biosensor Inc. made a splash in its KOSPI board debut on July 16, raising a total ₩776.4 billion (US$679.26 million). The company will now use the funds to mass-produce and promote the company’s ...

Agreement supports development and availability of an affordable, high-quality enzyme deficiency test SEATTLE, June 21, 2018 /PRNewswire/ -- PATH announced today a new partnership with South Korean ...

SD Biosensor was officially invited to the JP Morgan Healthcare Conference and presented in the APAC & LaTam section on January 10 (local time). During the presentation, Chief Operating Officer Serena ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

According to terms of the deal, Meridian shareholders will receive $34 per share When the deal closes, Meridian will no longer trade on the NASDAQ or any public securities exchange Rothschild & Co is ...